The success of biopharmaceuticals as highly effective clinical drugs has recently led industrial biotechnology towards their large-scale production. The ovary cells of the Chinese hamster (CHO cells) are one of the most common production cell line. However, they are very inefficient in producing desired compounds. This limitation can be tackled by culture bioengineering, but identifying the optimal interventions is usually expensive and time-consuming. In this study, we combined machine learning techniques with metabolic modelling to estimate lactate production in CHO cell cultures. We trained our poly-omics method using gene expression data from varying conditions and associated reaction rates in metabolic pathways, reconstructed in silico. The poly-omics reconstruction is performed by generating a set of condition-specific metabolic models, specifically optimised for lactate export estimation. To validate our approach, we compared predicted lactate production with experimentally measured yields in a cross-validation setting. Importantly, we observe that integration of metabolic predictions significantly improves the predictive ability of our machine learning pipeline when compared to the same pipeline based on gene expression alone. Our results suggest that, compared to transcriptomic-only studies, combining metabolic modelling with data-driven methods vastly improves the automatisation of cultures design, by accurately identifying optimal growth conditions for producing target therapeutic compounds.
Introduction
Chinese hamster ovary (CHO) cells are widely regarded as one of the most reliable cell types for industrial-scale mammalian protein production. As compared to bacterial cell lines such as those of Escherichia coli, CHO cultured cells are less productive, much fragile and grow slowly. In turn, this means that the manufacturing methods that facilitate protein production using CHO cell lines are much more expensive and time-consuming. However, heavy interest is put in optimising CHO cell lines as they are required to produce mammalian recombinant proteins.
Recent advances in this context have focused on unraveling the complex biological machinery controlling desirable characteristics of protein synthesis and secretion [1] . While gene expression profiling has proved helpful in past studies, there have been recent efforts to combine genetic data with knowledge of metabolic pathways through the reconstruction of genome-scale metabolic models (GSMMs). GSMMs attempt to describe cellular metabolism in silico through gene annotation and stoichiometry associated with reactions and metabolites, as well as with constraints such as upper or lower bounding of metabolic flux rates. Flux balance analysis (FBA) allows to predict the configuration of metabolic reaction fluxes within GSMMs under general growth conditions [2] . Condition-specific GSMMs can be built using a variety of methods and extended FBA pipelines. The idea is to use omic-data available in each condition, and a set of rules to constrain the flux rates of the general-purpose GSMM [20, 21] .
Metabolic models have recently been reconstructed for CHO-K1, CHO-S, and CHO-DG44 cell lines, along with a general consensus model [3] . These models were useful in quantifying the protein synthesis capacity of these cell lines and revealed that bioprocessing treatments such as histone deacetylase inhibitors' lead to an inefficiency in increasing product yield. FBA can thus reveal the impact of various media and culture conditions on growth and yield of cultured cells, aiding CHO cells bioengineering [3] [4] [5] [6] . Moreover, computational estimation of metabolic fluxes can be an asset when experimental data is not available [7] .
However, the precision of GSMMs strongly depends on available pathway and biochemical knowledge. Especially when dealing with the complexity of mammalian cells, more advanced computational techniques may be necessary for an effective application to real problems within the bio-processing industry. In particular, machine learning coupled with computational modelling of CHO cells has the potential to effectively elucidate optimal bioengineering steps towards improved production of therapeutic metabolites and proteins [8] .
Here we present a new approach integrating machine learning and metabolic modelling for the computational prediction of protein production in CHO cells. We propose to integrate experimental data on the gene level with data generated in silico via a GSMM of CHO cells metabolism within an integrated data-driven framework ( Figure 1 ). We evaluated this approach by a computational validation, estimating the average prediction error in general settings. Importantly, we observe that metabolic predictions coupled with gene expression data can significantly improve estimations of lactate production based solely on gene expression. 
Materials and Methods

Publicly available gene expression data
As a first data source, a large-scale gene expression dataset from two different CHO cell lines was used [9] . This dataset contains 295 microarray profiles with expression values for 3592 genes from 121 CHO cell cultures of varying conditions in terms of including cell density, growth rate, viability, lactate and ammonium accumulation and cell productivity. We extracted the 127 profiles with available quantification of lactate accumulation.
Genome scale reconstruction of CHO metabolism
We used a recently developed GSMM of CHO cell metabolism, previously used to accurately predict growth phenotypes [3] . This model is the largest reconstruction of CHO metabolism to date, with 1766 genes and 6663 reactions, aggregating community knowledge from various sources. Being a consensus model, it provides general mechanistic relationships that can be refined depending on the particular task or cell line of interest.
Building condition-specific poly-omics models of CHO cells
To create condition and cell line-specific poly-omics models the genome-scale model of CHO cell metabolism was combined with the gene expression data from CHO cell cultures in varying conditions. In this step, data accessible via the BIGG repository was employed to match gene identifiers [10] . A model for each condition was created by computing gene set effective expressions Θ for each reaction, following previous investigations [11, 12] . The effective expression at reaction level is thereby determined by gene expressions θ(g) and by gene-proteinreaction rules, properly converted to min/max rules depending on the type of gene set. In particular, we define Θ(g) = θ(g) for single genes, Θ(g1 ∧ g2) = min{θ(g1), θ(g2)} for enzymatic complexes and Θ(g1 ∨ g2) = max{θ(g1), θ(g2)} for isozymes. Lower bounds and upper bounds for each reaction were obtained by applying the following multiplicative coefficient to its native bounds:
where γ is a parameter controlling the impact of gene expression on reaction bounds.
Extraction of metabolic features
After a model for each condition was created, flux distributions were computed using FBA by maximising the biomass for producing cell lines included in the CHO model [3] . To perform FBA we employed the COBRA toolbox and a multi-level linear program structure [13, 24] . All simulations were carried out in Matlab R2014b with the Gurobi solver.
Feature processing and selection
Principle Component Analysis (PCA) is a very effective statistical tool that uses an orthogonal transformation to reduce a set of variables to a smaller set of linearly uncorrelated variables, known as the principle components [14] . Here PCA was used to process metabolic flux features in order to extract informative metabolic features.
Moreover, elastic net was applied to select relevant features, both at a gene expression and metabolic level [15] . Given an α in the interval ]0, 1] and a nonnegative λ, elastic net solves the following optimisation problem:
In this formula, x represents the gene expression and metabolic flux rates variables, y corresponds to measured metabolite yield and N is the total number of training conditions. Pα(β) is a regularisation term depending on a vector of linear coefficients β and on parameter α. Non-null entries of β resulting from this minimisation correspond to relevant features selected by elastic net.
Training generalised linear models to predict metabolite/protein production
Generalised linear models (GLM) were trained to predict lactate yield starting from poly-omics information [16] . A GLM gives an estimate of metabolite production yi pred calculated as follows:
GLM accuracy was assessed by nested cross-validation, consisting of two cross-validation loops which together evaluate a selected model based on training data [17] . The nested loop selects the values of α and λ of elastic net on 5 training and test folds. The outer loop is used for model evaluation and is ran over 10 folds. GLM accuracy for each test fold was evaluated by computing the root-meansquare error (RMSE) defined by the following formula:
where n is the number of test conditions in the fold.
Results
Metabolic model optimisation
We validated our proposed approach on the prediction of lactate production, resorting to experimental data from the study of Clarke et al. [9] . We selected the conditions with both microarray and measured lactate production, obtaining 127 conditions. In order to optimise metabolic flux information, we performed a sensitivity analysis on the gene expression mapping parameter γ in Equation (1) . Specifically, we studied the Pearson correlation r between measured lactate accumulation in culture media and simulated lactate export rates for varying values of γ across several orders of magnitude. The maximum correlation coefficient obtained was r = 0.36 (p-value = 2.6·10 -5 ). The relationships between these two quantities can be visualised in Figure 2a . We thus employed conditionspecific models with the optimal γ to generate fluxes for the following analysis. Validation results of the proposed approach on lactate production prediction: (a) comparison between simulated lactate export through condition-specific GSMMs and measured lactate production; this step enables GSMMs optimisation for the target metabolite in the following step; (b) RMSE distribution plots for lactate production predictions as a function of employed data sources. Two outliers for the green box lie outside of the current scale.
Predictions of lactate production
To accurately predict lactate production in CHO cells, we employed elastic net and GLMs as described in the Methods section. We estimated the generalised prediction error by means of a 10-fold cross-validation, repeatedly swapping conditions used in training and in tests [17] . We calculated the RMSE of predicted lactate yield across the test conditions in each fold, which quantifies the average difference between predicted and experimentally measured lactate yield. We repeated this procedure under three data sources scenarios, where gene expression, metabolic fluxes and their combination was evaluated separately. The results are shown in Figure 2b and summarised in Table 1 . Interestingly, although flux rates alone lead to poor predictions, if combined with gene expression they achieve the minor average and median RMSE across the 10 folds. In the latter case, associated RMSE distribution is significantly different to that obtained from gene expression alone on the basis of a one-tailed Wilcoxon rank sum test at a 5% threshold (p-value = 0.027) [18] . Figure 2b .
Discussion
The growing demand for natural products in global healthcare requires advanced automation of CHO cell culture design for biotechnological industry to reach commercial-scale production levels. Notably, recent advances in metabolic modelling and in data-driven prediction algorithms have not been yet exploited in combination for this purpose. In this study, we started to explore this research line: the overall goal of the work was to develop a poly-omics approach capable of predicting metabolite/protein production in CHO cells. The approach comprises a GLM trained on gene expression data originating from cultures in varying conditions and on metabolic flux rates obtained in silico from FBA on a GSMM of CHO metabolism. The accuracy of our approach was evaluated in comparison to GLMs employing only a single type of data. This allowed us to show that combining gene expression and metabolic fluxes improves accuracy compared to just using gene expression or metabolic fluxes separately.
Generation of condition-specific metabolic information can in principle be achieved through various types of computational analysis. In this study, we used FBA as this is the most widely used technique to capture flux configurations in a growth steady state [2] . In principle, different techniques could potentially extract even more useful information, further improving final data-driven predictions. For instance, in a preliminary evaluation we tested also a modified version of parsimonious enzyme usage FBA minimising the norm-2 of reaction fluxes [22, 23] . However, we observed that normal FBA achieved best results (data not shown).
The main limitation of this work is represented by a scarce availability of largescale public data on CHO cells and by the prototypical state of present GSMMs. Proposed strategies for model refining are expected to lead to further prediction improvements [19] . With more comprehensive datasets, both in terms of number of samples and in terms of metabolic gene coverage, we expect our pipeline to vastly improve its predictive ability. Moreover, although our validation focussed on lactate production, the proposed methodological framework can be straightforwardly implemented around any target metabolite or protein.
Despite the above-mentioned limitations, our results show that metabolismbased machine learning methods can significantly improve the predictive power of common transcriptomic-only methods. This is due to the introduction of metabolic features coupled with transcriptomic features. The present study therefore represents a preliminary assessment that we plan to extend in future investigations.
